Bonifacio, Rosalyn L.

HRN: 10-58-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
AMPICILLIN 1GM (VIAL)
09/14/2022
09/21/2022
IV
2grams
Q6
Premature Rupture Of Membranes; TMSAF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: